Insulet EBITDA 2010-2024 | PODD
Insulet annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Insulet EBITDA for the quarter ending March 31, 2024 was $0.076B, a 68.6% increase year-over-year.
- Insulet EBITDA for the twelve months ending March 31, 2024 was $0.324B, a 249.84% increase year-over-year.
- Insulet 2023 annual EBITDA was $0.293B, a 190.48% increase from 2022.
- Insulet 2022 annual EBITDA was $0.101B, a 45.04% decline from 2021.
- Insulet 2021 annual EBITDA was $0.183B, a 71.56% increase from 2020.
| Insulet Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $293 |
| 2022 | $101 |
| 2021 | $183 |
| 2020 | $107 |
| 2019 | $78 |
| 2018 | $43 |
| 2017 | $7 |
| 2016 | $3 |
| 2015 | $-33 |
| 2014 | $3 |
| 2013 | $-17 |
| 2012 | $-25 |
| 2011 | $-34 |
| 2010 | $-34 |
| 2009 | $-49 |
| Insulet Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $76 |
| 2023-12-31 | $125 |
| 2023-09-30 | $74 |
| 2023-06-30 | $49 |
| 2023-03-31 | $45 |
| 2022-12-31 | $40 |
| 2022-09-30 | $19 |
| 2022-06-30 | $-11 |
| 2022-03-31 | $53 |
| 2021-12-31 | $65 |
| 2021-09-30 | $48 |
| 2021-06-30 | $42 |
| 2021-03-31 | $29 |
| 2020-12-31 | $18 |
| 2020-09-30 | $35 |
| 2020-06-30 | $37 |
| 2020-03-31 | $16 |
| 2019-12-31 | $27 |
| 2019-09-30 | $25 |
| 2019-06-30 | $14 |
| 2019-03-31 | $12 |
| 2018-12-31 | $21 |
| 2018-09-30 | $11 |
| 2018-06-30 | $8 |
| 2018-03-31 | $4 |
| 2017-12-31 | $3 |
| 2017-09-30 | $6 |
| 2017-06-30 | $0 |
| 2017-03-31 | $-2 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $6 |
| 2016-06-30 | $2 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-8 |
| 2015-09-30 | $-11 |
| 2015-06-30 | $-10 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $4 |
| 2014-09-30 | $0 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $1 |
| 2013-12-31 | $3 |
| 2013-09-30 | $-14 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-3 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-6 |
| 2012-06-30 | $-8 |
| 2012-03-31 | $-8 |
| 2011-12-31 | $-8 |
| 2011-09-30 | $-7 |
| 2011-06-30 | $-13 |
| 2011-03-31 | $-6 |
| 2010-12-31 | $-14 |
| 2010-09-30 | $-5 |
| 2010-06-30 | $-7 |
| 2010-03-31 | $-8 |
| 2009-12-31 | $-9 |
| 2009-09-30 | $-11 |
| 2009-06-30 | $-13 |
| 2009-03-31 | $-15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $14.497B | $1.697B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.053B | 23.84 |
| Stryker (SYK) | United States | $129.729B | 31.07 |
| Boston Scientific (BSX) | United States | $112.966B | 35.98 |
| Medtronic (MDT) | Ireland | $101.722B | 15.23 |
| EssilorLuxottica (ESLOY) | France | $99.494B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.384B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.493B | 28.10 |
| ResMed (RMD) | United States | $28.144B | 26.42 |
| Terumo (TRUMY) | Japan | $24.477B | 34.57 |
| Koninklijke Philips (PHG) | Netherlands | $23.276B | 18.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.297B | 14.24 |
| Baxter (BAX) | United States | $17.081B | 12.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.820B | 0.00 |
| Demant (WILYY) | Denmark | $9.620B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.758B | 25.37 |
| BellRing Brands (BRBR) | United States | $7.565B | 35.58 |
| Lantheus Holdings (LNTH) | United States | $5.636B | 14.04 |
| Haemonetics (HAE) | United States | $4.238B | 20.90 |
| GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.54 |
| Perrigo (PRGO) | Ireland | $3.467B | 10.51 |
| Neogen (NEOG) | United States | $3.457B | 33.25 |
| ICU Medical (ICUI) | United States | $2.893B | 25.53 |
| Envista Holdings (NVST) | United States | $2.832B | 11.69 |
| TG Therapeutics (TGTX) | United States | $2.774B | 78.04 |
| Green Thumb Industries (GTBIF) | United States | $2.724B | 53.33 |
| Agios Pharmaceuticals (AGIO) | United States | $2.476B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.246B | 12.47 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.784B | 0.00 |
| Warby Parker (WRBY) | United States | $1.611B | 0.00 |
| InMode (INMD) | Israel | $1.517B | 8.06 |
| Verano Holdings (VRNOF) | United States | $1.455B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.313B | 9.76 |
| AtriCure (ATRC) | United States | $1.108B | 0.00 |
| Owens & Minor (OMI) | United States | $1.051B | 9.16 |
| National Vision Holdings (EYE) | United States | $0.995B | 31.67 |
| BioLife Solutions (BLFS) | United States | $0.944B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.871B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.697B | 14.83 |
| Evolus (EOLS) | United States | $0.684B | 0.00 |
| PetIQ (PETQ) | United States | $0.659B | 21.31 |
| Surmodics (SRDX) | United States | $0.598B | 37.47 |
| VAREX IMAGING (VREX) | United States | $0.598B | 14.06 |
| Canopy Growth (CGC) | Canada | $0.508B | 0.00 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| ZimVie (ZIMV) | United States | $0.480B | 40.91 |
| Biote (BTMD) | United States | $0.458B | 10.56 |
| TerrAscend (TSNDF) | Canada | $0.426B | 0.00 |
| Jin Medical (ZJYL) | China | $0.398B | 0.00 |
| Cerus (CERS) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
| Zynex (ZYXI) | United States | $0.287B | 39.26 |
| Ayr Wellness (AYRWF) | United States | $0.266B | 0.00 |
| MacroGenics (MGNX) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.251B | 24.89 |
| Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.86 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.152B | 21.57 |
| Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.109B | 0.00 |
| Brainsway (BWAY) | Israel | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 10.11 |
| InterCure (INCR) | Israel | $0.090B | 15.15 |
| Cellectar Biosciences (CLRB) | United States | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.080B | 0.00 |
| Bright Green (BGXX) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
| Allurion Technologies (ALUR) | United States | $0.062B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.47 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |